Data Foundry

Drug recalls 2016

buPROPion Hydrochloride Extended Release Tablets USP — Class III drug recall D-1446-2016

Terminated recall by Sun Pharmaceutical Industries, Inc., reported 2016-07-27, distributed nationwide. Failed Dissolution Specifications

Recall numberD-1446-2016
Product typeDrug
ClassificationClass III
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmSun Pharmaceutical Industries, Inc., Cranbury, NJ, United States
Recall initiated2016-06-27
Classified2016-07-20
Reported by FDA2016-07-27
Terminated2018-03-27
DistributedNationwide (US)
Quantity16,085 bottles
Reason classesspecification failure
NDC47335-0736, 47335-0736-08, 47335-0736-13, 47335-0736-86, 47335-0736-88, 47335-0737, 47335-0737-08, 47335-0737-13, 47335-0737-86, 47335-0737-88, 47335-0738, 47335-0738-08, 47335-0738-13, 47335-0738-86, 47335-0738-88
Lot numbersJKN3477A
Expiration dates2016-07

Product

buPROPion Hydrochloride Extended Release Tablets USP (SR) 150 mg Rx Only 60 tablets Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol 389-350 Gujarat India ---- NDC 47335-737-86

Reason for recall

Failed Dissolution Specifications

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1446-2016. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.